Jan 10 (Reuters) - Elon Musk said on Saturday that social media platform X will open to the public its new algorithm, including all code for organic and advertising post recommendations, in seven days ...
In the fall of 2025, I had the great pleasure of attending Tokyo Game Show, a trip that also naturally included a few pit stops to meet local developers and see what they were up to. On the very last ...
Amazon Q Developer is a useful AI-powered coding assistant with chat, CLI, Model Context Protocol and agent support, and AWS expertise. When I reviewed Amazon Q Developer in 2024, I noted that it was ...
In the wake of its dramatic split with developer Colossal Order, Cities Skylines 2 has launched new DLC made by the community. 'Creator packs' have long been a part of Cities Skylines, with dozens of ...
FESTUS, Mo. — The developers of a data center that caused a city-wide ban in St. Charles have proposed a new hyperscale site in Festus. CRG, a data center development firm owned by Clayco, has ...
The takeaway: Steam's longstanding dominance in the PC gaming market often raises questions about how close it is to exercising monopoly power. Although the storefront does not meet the technical ...
Welcome to the Dark Place is inspired by Zork and Kentucky Route Zero. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.
Resident Evil has been one of the video game industry's quintessential, flagship horror games for years now, delivering everything over the years from unsettling, atmospheric haunting to outright ...
Stocking your pantry with these staples is the first step to diving into Korean cuisine. Sara Park, a Korean-American food creator, has built a loyal following by sharing daily content that blends ...
The tentative deal comes on top of the billions in government aid that already benefited the firm, Related Companies, when the first phase was built. The area that is now Hudson Yards was formerly a ...
Pfizer said it would acquire weight loss biotech Metsera in a deal valued at up to $7.3 billion, including future payments, as it scrambles to win a slice in the booming obesity drug market. The move ...